对Arp2/3复合物的两个类型的小分子抑制剂的表征
B J Nolen1, N Tomasevic, A Russell
1Department of Molecular Cellular and Developmental Biology, Yale University, New Haven, Connecticut 06520, USA.
Nature
|August 4, 2009
概括
研究人员开发了两种小分子抑制剂,向与行动蛋白相关的蛋白质 (Arp) 2/3 复合体,这对细胞运动至关重要. 这些化合物为研究活细胞中的Arp2/3复杂功能提供了一种新途径.
科学领域:
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 由Arp2/3复合体调节的动氨酸丝聚合,驱动细胞运动.
- 了解Arp2/3在神经元生长指导和其他过程中的复杂作用是由于缺乏活细胞研究可逆抑制剂而受到限制的.
研究的目的:
- 开发和表征新的小分子,可逆抑制Arp2/3复杂介导的活细胞中的活性核.
主要方法:
- 针对Arp2/3复合体的小分子的选和表征.
- 生物化学试验,以评估抑制动氨酸丝核的抑制.
- 基于细胞的测定检查抑制Listeria彗星尾巴的形成和单细胞基组组装.
主要成果:
- 确定了两个不同的类型的小分子抑制剂 (CK-0944636和CK-0993548),它们与Arp2/3复合体的不同部位结合.
- CK-0944636通过阻断Arp2/3形状变化来抑制Arp2/3复合物的活性,而CK-0993548改变了Arp3形状.
- 这两种抑制剂都有效地抑制了Arp2/3复合物依赖的活性蛋白结构,包括Listeria活性蛋白彗星尾巴和单细胞基因组.
结论:
- 新型小分子为活细胞中Arp2/3复合体功能的可逆抑制和研究提供了强大的工具.
- 这些抑制剂有助于研究Arp2/3复合物介导的动氨酸核化对各种细胞过程的具体贡献.
相关概念视频
Generation of Straight or Branched Actin Filaments
2.9K
The straight or branched structure formation of actin filaments is controlled by nucleating proteins such as the formins and Arp2/3 complex. Formin-mediated assembly results in straight filaments, whereas Arp2/3 protein complex-mediated assembly results in branched actin filaments.
Arp2/3 Complex
Arp2/3 complex is a seven-subunit complex consisting of two proteins similar to actin- Arp2 and Arp3, and five other subunits that help keep Arp2 and Arp3 inactive. When required, the complex is...
Arp2/3 Complex
Arp2/3 complex is a seven-subunit complex consisting of two proteins similar to actin- Arp2 and Arp3, and five other subunits that help keep Arp2 and Arp3 inactive. When required, the complex is...
2.9K
Actin Filament Depolymerization
3.0K
Actin filaments (F-actin) are composed of actin subunits. The dissociation of actin monomers can occur from either end of F-actin. The rate of dissociation is faster from the minus-end or the pointed end, where the actin subunits exist with a bound ADP, together known as ADP-actin. The depolymerization of F-actin is aided by proteins, including the actin-depolymerizing factor (ADF) and cofilin family of proteins, gelsolin, and glia maturation factor (GMF).
In F-actin, the ADF/cofilin proteins...
In F-actin, the ADF/cofilin proteins...
3.0K
GPCR Desensitization
6.1K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K
Combined Effects of Drugs: Antagonism
11.6K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.6K
The Two-State Receptor Model
3.5K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.5K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K


